SCHEMBL30730263

SCHEMBL30730263

CC(C)(C(=O)NN)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
GAA P10253 1/20 0.44
SSTR4 P31391 1/20 0.43
TSHR P16473 2/20 0.42
CYP2C19 P33261 1/20 0.39
ALDH1A1 P00352 1/20 0.39
EPHX1 P07099 1/20 0.38
EPHX2 P34913 1/20 0.38
POLB P06746 1/20 0.38
IDO1 P14902 1/20 0.38
HCRTR1 O43613 1/20 0.38
HCRTR2 O43614 1/20 0.38
FFAR2 O15552 1/20 0.37
CYP3A4 P08684 1/20 0.37
APEX1 P27695 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30443832 0.84 TSHR (0.44) HDAC3HDAC1HDAC2HDAC6SSTR4
SCHEMBL10228105 0.83 KMO (0.42) HDAC6GAACYP2C19ALDH1A1CYP3A4
Hydrochloric Acid SCHEMBL604111 0.82 KMO (0.41) HDAC6GAACYP2C19ALDH1A1CYP3A4
SCHEMBL8443184 0.80 KMT2A (0.52) HDAC3HDAC1HDAC2HDAC6SSTR4
SCHEMBL3323151 0.80 FFAR2 (0.52) CYP2C19ALDH1A1POLBFFAR2MEN1
SCHEMBL30730227 0.79 GAA (0.44) HDAC3HDAC1HDAC2HDAC6GAA
SCHEMBL27329721 0.79 GAA (0.44) HDAC3HDAC1HDAC2HDAC6GAA
SCHEMBL10228094 0.79 NPC1 (0.38) HDAC1HDAC6ALDH1A1POLBKMT2A
SCHEMBL1626481 0.78 AKR1C3 (0.51) HDAC3HDAC1HDAC2HDAC6SSTR4
SCHEMBL1627092 0.78 TSHR (0.48) HDAC3HDAC1HDAC2HDAC6SSTR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4562015-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME Cedilla Therapeutics, Inc. (US) 2025-06-04 EP disclosed
WO-2024026481-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME CEDILLA THERAPEUTICS, INC. (US) 2024-02-01 WO disclosed